Cedric CHAVEROUX
Equipe : Protéines matricellulaires et Dérégulations Pathologiques
Courriel : cedric.chaveroux@cnrs.fr
Téléphone : +33(0)4-72-72-26-05
Statut :
4 publications au total. Seules les 5 dernières années sont affichées
2024
4. Combined effects of exercise and immuno-chemotherapy treatments on tumor growth in MC38 colorectal cancer-bearing mice.
Gouez M, Rébillard A, Thomas A, Beaumel S, Matera El, Gouraud E, Orfila L, Martin B, Pérol O, Chaveroux C, Chirico En, Dumontet C, Fervers B, Pialoux V
(2024) Front Immunol 15 :1368550-1368550
3. Soft extracellular matrix drives endoplasmic reticulum stress-dependent S quiescence underlying molecular traits of pulmonary basal cells.
Laval Pa, Piecyk M, Guen Pl, Ilie Md, Marion A, Fauvre J, Coste I, Renno T, Aznar N, Hadji C, Migdal C, Duret C, Bertolino P, Ferraro-peyret C, Nicolas A, Chaveroux C
(2024) Acta Biomater 182 :93-110
2. Novel insights into the GCN2 pathway and its targeting. Therapeutic value in cancer and lessons from lung fibrosis development.
Piecyk M, Ferraro-peyret C, Laville D, Perros F, Chaveroux C
(2024) Febs J 291 :4867-4889
1. Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death.
Virard F, Giraud S, Bonnet M, Magadoux L, Martin L, Pham Th, Skafi N, Deneuve S, Frem R, Villoutreix Bo, Sleiman Nh, Reboulet J, Merabet S, Chaptal V, Chaveroux C, Hussein N, Aznar N, Fenouil T, Treilleux I, Saintigny P, Ansieau S, Manié S, Lebecque S, Renno T, Coste I
(2024) Nat Commun 15 :7037-7037
